NanoViricides is trading 6.51% down now at $1.33 after no company-specific announcement was identified for August 8–10, 2026.
- The investor-relations page lists July 28, 2026, as its latest press release.
- No new earnings, financing, regulatory, clinical-trial, or corporate announcement was identified after August 7, 2026.
- Broader markets are mixed; the catalyst remains unclear and may reflect limited liquidity or unreported trading activity.